FR2385398B1 - - Google Patents

Info

Publication number
FR2385398B1
FR2385398B1 FR7808745A FR7808745A FR2385398B1 FR 2385398 B1 FR2385398 B1 FR 2385398B1 FR 7808745 A FR7808745 A FR 7808745A FR 7808745 A FR7808745 A FR 7808745A FR 2385398 B1 FR2385398 B1 FR 2385398B1
Authority
FR
France
Prior art keywords
cl2mdp
indoxole
ehdp
indomethacin
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7808745A
Other languages
English (en)
Other versions
FR2385398A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of FR2385398A1 publication Critical patent/FR2385398A1/fr
Application granted granted Critical
Publication of FR2385398B1 publication Critical patent/FR2385398B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
FR7808745A 1977-03-28 1978-03-24 Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate Granted FR2385398A1 (fr)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US78214477A 1977-03-28 1977-03-28
US78214377A 1977-03-28 1977-03-28
US80189677A 1977-05-31 1977-05-31
US80170777A 1977-05-31 1977-05-31
US80170577A 1977-05-31 1977-05-31
US80189577A 1977-05-31 1977-05-31
US80170477A 1977-05-31 1977-05-31
CH601678A CH645542A5 (de) 1977-03-28 1978-06-01 Entzuendungshemmende arzneimittelpraeparate.
SE7806449A SE441493B (sv) 1977-03-28 1978-06-01 Antiinflammatorisk komposition innefattande en salicylsyrabaserad, antiinflammatorisk forening och ett organofosfonat
SE8001363A SE441494B (sv) 1977-03-28 1980-02-21 Antiinflammatorisk komposition innefattande en indolbaserad, antiinflammatorisk forening och ett organofosfonat

Publications (2)

Publication Number Publication Date
FR2385398A1 FR2385398A1 (fr) 1978-10-27
FR2385398B1 true FR2385398B1 (fr) 1980-04-04

Family

ID=27579075

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7808745A Granted FR2385398A1 (fr) 1977-03-28 1978-03-24 Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate

Country Status (11)

Country Link
US (1) US4269828A (fr)
JP (1) JPS542340A (fr)
AU (1) AU524180B2 (fr)
BE (1) BE865370A (fr)
CA (1) CA1109794A (fr)
CH (1) CH645542A5 (fr)
DE (1) DE2813165C2 (fr)
FR (1) FR2385398A1 (fr)
GB (1) GB1588284A (fr)
NL (2) NL175882B (fr)
SE (2) SE441493B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1229554A (fr) * 1983-04-18 1987-11-24 Warner-Lambert Company Compose pharmaceutique topique d'acide meclofenamique
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
DE3324193A1 (de) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
JPH0639449B2 (ja) * 1989-04-10 1994-05-25 エーザイ株式会社 ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
EP0550385A1 (fr) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Compositions pharmaceutiques orales contenant des dérivés d'acide méthane-diphosphonique et des éthers 18-couronne-6
CA2138366C (fr) * 1992-06-30 1998-09-22 Kristine Hovancik Methodes pour le traitement de l'arthrite au moyen de phosphonates et d'ains
SE9303740L (sv) * 1993-11-12 1995-05-13 Leiras Oy Farmaceutisk komposition
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals
WO1997013519A1 (fr) * 1995-10-09 1997-04-17 Russinsky Limited Esters d'inhibiteurs de cyclooxygenase et derives terpeniques utilises comme produits pharmaceutiques
DE19615577A1 (de) * 1996-04-19 1997-10-23 Beiersdorf Ag Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
SE9703691D0 (sv) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
DE10049735A1 (de) * 2000-09-28 2002-04-18 Jenapharm Gmbh Verfahren zur Isolierung von pharmazeutisch verwertbarem Etidronat-Dinatrium
AUPR283801A0 (en) * 2001-02-01 2001-03-01 Australian National University, The Chemical compounds and methods
DK2421513T3 (en) 2009-04-24 2018-03-26 Iceutica Pty Ltd UNKNOWN FORMULATION WITH INDOMETHACIN

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584125A (en) * 1968-12-23 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3553314A (en) * 1968-12-23 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3584124A (en) * 1968-12-24 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3553315A (en) * 1968-12-24 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3678164A (en) * 1969-02-12 1972-07-18 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3641246A (en) * 1970-01-14 1972-02-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phcosphate in animal tissue
US3662066A (en) * 1970-03-04 1972-05-09 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4044125A (en) * 1975-07-18 1977-08-23 Eli Lilly And Company Method of stabilizing acetylsalicylic acid in the presence of d-propoxyphene hydrochloride and compositions thereof
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin

Also Published As

Publication number Publication date
US4269828A (en) 1981-05-26
JPS542340A (en) 1979-01-09
GB1588284A (en) 1981-04-23
NL7803247A (nl) 1978-10-02
CH645542A5 (de) 1984-10-15
FR2385398A1 (fr) 1978-10-27
AU524180B2 (en) 1982-09-02
AU3451178A (en) 1979-10-04
DE2813165C2 (de) 1983-12-15
SE8001363L (sv) 1980-02-21
SE441494B (sv) 1985-10-14
NL175882B (nl) 1984-08-16
SE7806449L (sv) 1979-12-02
NL175882C (nl)
CA1109794A (fr) 1981-09-29
DE2813165A1 (de) 1978-10-12
SE441493B (sv) 1985-10-14
BE865370A (fr) 1978-09-28

Similar Documents

Publication Publication Date Title
FR2385398B1 (fr)
NO880950D0 (no) Fremgangsmaate for fremstilling av oksygen med hoey renhet.
DK393187A (da) Laegemiddel med antitumorvirkning
AU503218B2 (en) The production of mg and ca by carbon reduction
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
USD246600S (en) Test tube
USD254155S (en) Electric lamp
USD250349S (en) Catheter
NL172157C (nl) Preparaat met bloeddrukverlagende werking en de daarvoor geschikte werkzame verbindingen.
DK165966C (da) Forbedret piroxicamholdigt anti-inflammatorisk praeparat
USD243122S (en) Medicinal applicator or the like
USD244623S (en) Aquarium
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
USD249483S (en) Housing for fire and smoke detector
USD244295S (en) Ceiling tile
USD247580S (en) Face shield
USD249482S (en) Housing for fire and smoke detector
USD250770S (en) Needle
USD244296S (en) Ceiling tile
USD249401S (en) Hairbrush
USD244250S (en) Mophead
IT8020503A0 (it) Derivati della 1,1'-bifenil-2-ilalchilammina ad azione farmaceutica.
USD243337S (en) Dentist's syringe
USD244901S (en) Hanger body

Legal Events

Date Code Title Description
ST Notification of lapse